Amalgamated Bank’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-138
Closed -$7K 3030
2022
Q1
$7K Buy
+138
New +$11.1K ﹤0.01% 2998

Other funds holding ALGS

Amalgamated Bank's ALGS Position: Q2 2022 in Review

Amalgamated Bank sold out of Aligos Therapeutics (ALGS) in Q2 2022, closing a stake of 138 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in ALGS in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 59 funds tracked by Wall St. Rank hold ALGS as of Q2 2022.

  • Amalgamated Bank reported no remaining Aligos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 138 Aligos Therapeutics shares in Q2 2022, an estimated $7K.
  • Amalgamated Bank first reported a position in Aligos Therapeutics in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Aligos Therapeutics position peaked at $7K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.